---
title: "Sonoscape Medical Corp. (300633.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300633.SZ.md"
symbol: "300633.SZ"
name: "Sonoscape Medical Corp."
industry: "Health Care Equipment"
datetime: "2026-05-21T10:07:42.886Z"
locales:
  - [en](https://longbridge.com/en/quote/300633.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300633.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300633.SZ.md)
---

# Sonoscape Medical Corp. (300633.SZ)

## Company Overview

SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. It offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image processors, light sources, gastroenterology and pulmonology products, endoscopic ultrasound, duodenoscopes, and peripheral equipment; minimally invasive surgery solutions, such as camera systems and flexible endoscopes; veterinary ultrasound and endoscopy solutions; and intravascular intervention products. The company also provides face-to-face and online training for ultrasound and endoscopy systems; technical and spare parts support; preventive maintenance, calibration, breakdown repair, and other field services; and upgrade services. In addition, it is involved in the software industry.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | CN Market |
| Website | [www.sonoscape.com](https://www.sonoscape.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:14.000Z

**Overall: B (0.32)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 13 / 64 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Growth - Stocks whose main business is in the growth stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 20.11% |  |
| Net Profit YoY | 253.21% |  |
| P/B Ratio | 2.98 |  |
| Dividend Ratio | 0.44% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 9695718545.85 |  |
| Revenue | 2355079914.01 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 5.56% | C |
| Profit Margin | 7.53% | B |
| Gross Margin | 61.44% | A |
| Revenue YoY | 20.11% | B |
| Net Profit YoY | 253.21% | A |
| Total Assets YoY | 7.59% | B |
| Net Assets YoY | 4.45% | C |
| Cash Flow Margin | 54.57% | C |
| OCF YoY | 20.11% | B |
| Turnover | 0.57 | C |
| Gearing Ratio | 24.09% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Sonoscape Medical Corp.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "20.11%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "253.21%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.98",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.44%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "9695718545.85",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "2355079914.01",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "5.56%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "7.53%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "61.44%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "20.11%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "253.21%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "7.59%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "4.45%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "54.57%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "20.11%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.57",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "24.09%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 54.70 | 32/64 | 296.04 | 186.73 | 169.41 |
| PB | 2.98 | 34/64 | 4.58 | 3.98 | 3.66 |
| PS (TTM) | 4.12 | 16/64 | 7.27 | 6.02 | 5.46 |
| Dividend Yield | 0.44% | 39/64 | 0.38% | 0.35% | 0.30% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | APT (688617.SH) | A | B | B | A | B | A |
| 02 | United Imaging Healthcare (688271.SH) | B | A | C | B | B | B |
| 03 | iRay (688301.SH) | B | A | D | C | A | B |
| 04 | YUYUE MEDICAL (002223.SZ) | B | C | C | A | C | B |
| 05 | Insight Lifetech (688712.SH) | B | A | E | A | A | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-19T16:00:00.000Z

Total Analysts: **7**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 4 | 57% |
| Overweight | 2 | 29% |
| Hold | 1 | 14% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 22.52 |
| Highest Target | 37.15 |
| Lowest Target | 29.90 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300633.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300633.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300633.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300633.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**